These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 17182988

  • 1. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS.
    N Engl J Med; 2006 Dec 21; 355(25):2631-9. PubMed ID: 17182988
    [Abstract] [Full Text] [Related]

  • 2. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS.
    N Engl J Med; 2004 Feb 12; 350(7):655-63. PubMed ID: 14960742
    [Abstract] [Full Text] [Related]

  • 3. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
    Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, Fox CS, Meigs JB, Levy D, Larson MG, Selhub J, D'Agostino RB, Wang TJ, Vasan RS.
    Circulation; 2007 Aug 28; 116(9):984-92. PubMed ID: 17698726
    [Abstract] [Full Text] [Related]

  • 4. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.
    J Hypertens; 2006 Aug 28; 24(8):1531-9. PubMed ID: 16877955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S, HOPE Study Investigators.
    Circulation; 2006 Jul 18; 114(3):201-8. PubMed ID: 16831981
    [Abstract] [Full Text] [Related]

  • 7. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):601-8. PubMed ID: 19660689
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, Chen JW, Lin SJ.
    Coron Artery Dis; 2008 May 11; 19(3):187-93. PubMed ID: 18418236
    [Abstract] [Full Text] [Related]

  • 11. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM.
    Circulation; 2008 Feb 12; 117(6):823-31. PubMed ID: 18227386
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.
    Kathiresan S, Gona P, Larson MG, Vita JA, Mitchell GF, Tofler GH, Levy D, Newton-Cheh C, Wang TJ, Benjamin EJ, Vasan RS.
    Circulation; 2006 Feb 21; 113(7):938-45. PubMed ID: 16476848
    [Abstract] [Full Text] [Related]

  • 14. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN, Tsiaousis GZ, Georgilas AT, Makrygiannis SS, Adamopoulou EN, Handanis SM, Batika PC, Prekates AA, Velissaris D, Kouris NT, Mytas DZ, Babalis DK, Karidis KS, Foussas SG.
    Int J Cardiol; 2010 Jun 11; 141(3):284-90. PubMed ID: 19157603
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.
    J Hypertens; 2008 Jan 11; 26(1):26-34. PubMed ID: 18090537
    [Abstract] [Full Text] [Related]

  • 17. Multiple biomarkers for mortality prediction in peripheral arterial disease.
    Amrock SM, Weitzman M.
    Vasc Med; 2016 Apr 11; 21(2):105-12. PubMed ID: 26762418
    [Abstract] [Full Text] [Related]

  • 18. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
    Güder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Störk S.
    Circulation; 2007 Apr 03; 115(13):1754-61. PubMed ID: 17372171
    [Abstract] [Full Text] [Related]

  • 19. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
    Bodí V, Sanchis J, Llàcer A, Fácila L, Núñez J, Pellicer M, Bertomeu V, Ruiz V, Chorro FJ.
    Am Heart J; 2005 Feb 03; 149(2):268-74. PubMed ID: 15846264
    [Abstract] [Full Text] [Related]

  • 20. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 03; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.